Celularity, Inc. (CELU)
1.01
+0.02
(+1.92%)
USD |
NASDAQ |
May 29, 16:00
1.02
+0.01
(+0.99%)
Pre-Market: 20:00
Celularity EPS Diluted (Quarterly) : -0.8477 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Tenax Therapeutics, Inc. | -0.3475 |
| Exicure, Inc. | -0.4547 |
| Century Therapeutics, Inc. | -0.1119 |
| Absci Corp. | -0.1935 |
| Cardio Diagnostics Holdings, Inc. | -0.6295 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -24.36M |
| Revenue (Quarterly) | 4.104M |
| Total Expenses (Quarterly) | 28.47M |
| Enterprise Value | 97.77M |
| Gross Profit Margin (Quarterly) | -123.6% |
| Profit Margin (Quarterly) | -593.6% |
| Earnings Yield | -354.9% |
| Normalized Earnings Yield | -315.05 |